carmustine has been researched along with nimustine in 45 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 16 (35.56) | 18.7374 |
1990's | 15 (33.33) | 18.2507 |
2000's | 9 (20.00) | 29.6817 |
2010's | 5 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Fan, T; Sun, G; Zhang, N; Zhang, S; Zhao, L; Zhong, R | 1 |
Lai, X; Ren, T; Sun, G; Wang, Y; Zhang, N; Zhao, L; Zhong, R | 1 |
Darling, JL; Hoffmann, O; Kraemer, HP; Nikkhah, G; Schachenmayr, W; Schönmayr, R; Tonn, JC | 1 |
Roosen, K; Schachenmayr, W; Tonn, JC | 1 |
Dahl, O; Schem, BC | 1 |
Erbersdobler, A; Gassmann, W; Glass, B; Löffler, H; Mueller-Ruchholtz, W; Schmitz, N; Uharek, L; Wottge, HU | 1 |
Arita, N; Bitoh, S; Hasegawa, H; Hayakawa, T; Ikeda, H; Kanai, N; Kanoh, M; Mogami, H; Oku, Y; Ushio, Y | 1 |
Heuser, K | 1 |
Kraemer, HP; Schönmayr, R; Tonn, JC | 2 |
Fields, WS; Iwata, K; Yung, WK | 1 |
Bamberg, M; Budach, W; Sprengel, M; Strehl, K; Stuschke, M | 1 |
Jaksche, H; Loew, F; Papavero, L | 1 |
Aida, T | 1 |
Ishii, H | 1 |
Bamberg, M; Budach, V; Gerhard, L; Stuschke, M | 1 |
Aida, T; Bodell, WJ | 2 |
Kamiya, S | 1 |
Aida, T; Berger, MS; Bodell, WJ; Gerosa, M; Rosenblum, ML | 1 |
Bosanquet, AG | 1 |
Hayakawa, T; Mogami, H; Nakata, Y; Sakamoto, Y; Shimizu, K; Ushio, Y; Yoshida, T | 2 |
Wakui, A | 1 |
Oguro, M; Takenaga, K; Yanagawa, T | 1 |
Krossnes, BK; Mella, O; Roszinski, S; Schem, BC | 1 |
Kuratsu, J; Ushio, Y | 1 |
Chen, JM; Chen, YN; Fan, GC; He, T; Wu, Y; Xu, HY; Zhang, YP | 1 |
Fujioka, K; Funabiki, T; Ikuta, K; Kai, S; Kajigaya, Y; Matsuyama, S; Sakai, H; Sekiguchi, H; Sumita, H; Takahashi, H | 1 |
Nemoto, S | 1 |
Kohda, K; Terashima, I | 1 |
Damian, MS; Leweke, F; Schachenmayr, W; Schindler, C | 1 |
Makhova, EV; Moshkovskaia, EIu; Vasil'eva, SV | 1 |
Weller, M; Winter, S | 1 |
Bardenheuer, W; Flasshove, M; Jansen, M; Moritz, T; Seeber, S; Sorg, UR | 1 |
Boiardi, A; Eoli, M; Erbetta, A; Fariselli, L; Salmaggi, A; Silvani, A | 1 |
Zhang, YP | 1 |
Shibui, S | 1 |
Berrak, S; Koontz Webb, SE; Wolff, JE; Zhang, M | 1 |
Ogawa, M; Ueda, T; Yamauchi, T | 1 |
Bekö, SL; Glaubitz, C; Lakatos, A; Schmidt, MU; Urmann, D | 1 |
Allgayer, H; Fruehauf, S; Heckmann, D; Laufs, S; Maier, P; Spier, I; Wenz, F; Zeller, WJ; Zucknick, M | 1 |
Kanamori, M; Kumabe, T; Mano, Y; Saito, R; Sonoda, Y; Tominaga, T; Zhang, R | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
5 review(s) available for carmustine and nimustine
Article | Year |
---|---|
Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. General considerations, the nitrosoureas and alkylating agents.
Topics: Alkylation; Antineoplastic Agents; Carmustine; Chlorambucil; Colony-Forming Units Assay; Cyclophosphamide; Drug Storage; Hydrogen-Ion Concentration; Lomustine; Mathematics; Melphalan; Nimustine; Nitrosourea Compounds; Solutions; Temperature; Tumor Stem Cell Assay | 1985 |
[Cancer chemotherapy with special reference to pharmacokinetics of nitrosoureas].
Topics: Carmustine; Humans; Kinetics; Lomustine; Neoplasms; Nimustine; Nitrosourea Compounds; Semustine; Solubility; Streptozocin | 1982 |
[Chemotherapy of brain tumors].
Topics: Blood-Brain Barrier; Brain Neoplasms; Carmustine; Chemotherapy, Adjuvant; Combined Modality Therapy; Glioma; Humans; Nimustine | 1994 |
[Study on MGMT assay and tumor individual predictable chemotherapy].
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Brain Neoplasms; Carmustine; Drug Resistance, Neoplasm; HeLa Cells; Humans; Mice; Mice, Nude; Neoplasms; Nimustine; O(6)-Methylguanine-DNA Methyltransferase; Reagent Kits, Diagnostic; RNA, Messenger | 2004 |
[Treatment for malignant glioma].
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Glioma; Humans; Nimustine | 2005 |
3 trial(s) available for carmustine and nimustine
Article | Year |
---|---|
Chemotherapy of brain metastases from lung carcinoma: a controlled randomized study.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma; Carcinoma, Squamous Cell; Carmustine; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nimustine; Radiotherapy Dosage; Remission Induction; Semustine; Survival Rate; Tegafur | 1991 |
[High-dose busulfan, VP-16 and ACNU therapy with stem cell transplantation for the treatment of children with acute leukemia].
Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Carmustine; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Male; Nimustine | 1993 |
Intra-arterial ACNU and carboplatin versus intravenous chemotherapy with cisplatin and BCNU in newly diagnosed patients with glioblastoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carmustine; Cisplatin; Drug Administration Routes; Female; Glioblastoma; Humans; Injections, Intra-Arterial; Injections, Intravenous; Karnofsky Performance Status; Male; Middle Aged; Nimustine | 2002 |
37 other study(ies) available for carmustine and nimustine
Article | Year |
---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Synthesis and antitumor activity evaluation of a novel combi-nitrosourea prodrug: Designed to release a DNA cross-linking agent and an inhibitor of O(6)-alkylguanine-DNA alkyltransferase.
Topics: Antineoplastic Agents; Cross-Linking Reagents; Enzyme Inhibitors; Humans; Nitrosourea Compounds; O(6)-Methylguanine-DNA Methyltransferase; Prodrugs | 2016 |
Synthesis and Antitumor Activity Evaluation of a Novel Combi-nitrosourea Prodrug: BGCNU.
Topics: | 2017 |
The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part II: Evaluation of patient- and drug-specific variables.
Topics: Antineoplastic Agents; Brain Neoplasms; Carmustine; Cell Survival; Colony-Forming Units Assay; Coloring Agents; Drug Screening Assays, Antitumor; Glioma; Humans; Mitomycin; Mitoxantrone; Nimustine; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1992 |
Brain necroses after intraarterial chemotherapy and irradiation of malignant gliomas--a complication of both ACNU and BCNU?
Topics: Brain; Brain Diseases; Brain Neoplasms; Carmustine; Chemotherapy, Adjuvant; Combined Modality Therapy; Cranial Irradiation; Glioma; Humans; Infusions, Intravenous; Injections, Intra-Arterial; Necrosis; Nimustine; Prospective Studies; Radiation Injuries | 1991 |
Thermal enhancement of ACNU and potentiation of thermochemotherapy with ACNU by hypertonic glucose in the BT4An rat glioma.
Topics: Animals; Brain Neoplasms; Carmustine; Combined Modality Therapy; Drug Screening Assays, Antitumor; Drug Synergism; Glioma; Glucose; Hydrogen-Ion Concentration; Hyperthermia, Induced; Hypertonic Solutions; Neoplasm Transplantation; Nimustine; Rats; Rats, Inbred Strains; Retinal Diseases; Skin Neoplasms; Tumor Cells, Cultured | 1991 |
High-dose cytostatic agents in allogeneic bone marrow transplantation: comparison of the engraftment promoting potential.
Topics: Animals; Antineoplastic Agents; Bone Marrow Transplantation; Carboplatin; Carmustine; Cyclophosphamide; Graft Rejection; Ifosfamide; Immunosuppression Therapy; Male; Melphalan; Nimustine; Rats; Rats, Inbred Lew; Thiotepa | 1991 |
[Chemotherapy in malignant gliomas].
Topics: Antineoplastic Agents; Brain Neoplasms; Carmustine; Combined Modality Therapy; Cytarabine; Follow-Up Studies; Glioma; Humans; Nimustine; Survival Rate; Teniposide | 1990 |
Sensitivity of human malignant intracranial tumors against MCNU in vitro in comparison to ACNU and BCNU.
Topics: Aged; Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Carmustine; Drug Screening Assays, Antitumor; Female; Glioma; Humans; Male; Middle Aged; Nimustine; Nitrosourea Compounds; Tumor Cells, Cultured | 1990 |
In vitro effects of ACNU, BCNU, CDDP, and bleomycin on human glioma cells.
Topics: Antineoplastic Agents; Bleomycin; Brain Neoplasms; Carmustine; Cell Line; Cisplatin; Drug Screening Assays, Antitumor; Glioblastoma; Humans; Nimustine; Tumor Cells, Cultured | 1988 |
Treatment of high grade glioma xenografts with nitrosoureas in nude mice.
Topics: Animals; Carmustine; Glioblastoma; Glioma; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Nimustine; Oligodendroglioma; Transplantation, Heterologous | 1989 |
Intracarotid infusion of ACNU and BCNU as adjuvant therapy of malignant gliomas. Clinical aspects and critical considerations.
Topics: Astrocytoma; Brain Neoplasms; Carmustine; Carotid Arteries; Combined Modality Therapy; Follow-Up Studies; Glioblastoma; Glioma; Humans; Infusions, Intra-Arterial; Neoplasm Recurrence, Local; Nimustine; Nitrosourea Compounds; Oligodendroglioma | 1987 |
[Mechanisms of cellular resistance to chloroethylnitrosourea in cell lines derived from human brain tumors].
Topics: Brain Neoplasms; Carmustine; Cell Line; DNA Damage; Drug Resistance; Glioma; Humans; Nimustine; Nitrosourea Compounds; Sister Chromatid Exchange; Tumor Cells, Cultured | 1988 |
Combination chemotherapy for multiple myeloma with melphalan, ifosfamide, prednisolone, nitrosourea and vincristine.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Female; Humans; Ifosfamide; Male; Melphalan; Middle Aged; Multiple Myeloma; Neoplasm Staging; Nimustine; Nitrosourea Compounds; Prednisolone; Prognosis; Vincristine | 1988 |
Preliminary experimental results with the nitrosourea derivative ACNU in the treatment of malignant gliomas.
Topics: Animals; Astrocytoma; Carmustine; Disease Models, Animal; Dose-Response Relationship, Drug; Lethal Dose 50; Mice; Mice, Nude; Nimustine; Nitrosourea Compounds; Oligodendroglioma; Transplantation, Heterologous | 1988 |
Cellular resistance to chloroethylnitrosoureas, nitrogen mustard, and cis-diamminedichloroplatinum(II) in human glial-derived cell lines.
Topics: Carmustine; Cell Line; Cell Survival; Cisplatin; DNA; Dose-Response Relationship, Drug; Drug Resistance; Glioma; Humans; Mechlorethamine; Methylation; Nimustine; Nitrosourea Compounds; Sister Chromatid Exchange | 1987 |
[Synthesis of antitumor nitrosourea derivatives and chemical studies of their mechanism of action].
Topics: Antineoplastic Agents; Bone Marrow; Carmustine; Humans; Lomustine; Nimustine; Nitroso Compounds; Nitrosourea Compounds | 1986 |
[Anticancer drug induced sister chromatid exchange and correlation to cell survival in human brain tumor cells].
Topics: Antineoplastic Agents; Brain Neoplasms; Carmustine; Cell Line; Cell Survival; Cisplatin; Glioma; Humans; Mechlorethamine; Nimustine; Nitrosourea Compounds; Sister Chromatid Exchange; Tumor Stem Cell Assay | 1987 |
Investigation of resistance to DNA cross-linking agents in 9L cell lines with different sensitivities to chloroethylnitrosoureas.
Topics: Animals; Antineoplastic Agents; Carmustine; Cell Line; Cell Survival; Cross-Linking Reagents; DNA; DNA Repair; Drug Resistance; Nimustine; Nitrosourea Compounds; Rats; Sister Chromatid Exchange | 1985 |
[Chemotherapy of experimental meningeal gliomatosis].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain; Carmustine; Glioma; Male; Meningeal Neoplasms; Nimustine; Nitrosourea Compounds; Rats; Rats, Inbred F344; Rats, Inbred Strains | 1984 |
[Meningeal gliomatosis models as a chemosensitivity assay system].
Topics: Animals; Antineoplastic Agents; Carmustine; Cell Division; Cell Survival; Disease Models, Animal; Drug Resistance; Glioma; Male; Meningeal Neoplasms; Nimustine; Nitrosourea Compounds; Rats; Rats, Inbred F344; Rats, Inbred Strains | 1984 |
[Antitumor activity of a new nitrosourea, MCNU, on a cellular morphological basis evaluated by a new in vitro antitumor sensitivity assay].
Topics: Animals; Antineoplastic Agents; Carmustine; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance; Humans; In Vitro Techniques; Leukemia L1210; Lomustine; Nimustine; Nitrosourea Compounds; Semustine; Tumor Stem Cell Assay | 1984 |
Timing of hypertonic glucose and thermochemotherapy with 1-(4-amino-2-methylpyrimidine-5-yl) methyl-3-(2-chloroethyl)-3-nitrosourea (ACNU) in the BT4An rat glioma: relation to intratumoral pH reduction and circulatory changes after glucose supply.
Topics: Animals; Antineoplastic Agents; Carmustine; Combined Modality Therapy; Drug Administration Schedule; Glioblastoma; Glucose Solution, Hypertonic; Hydrogen-Ion Concentration; Hyperthermia, Induced; Nimustine; Rats; Rats, Inbred Strains; Tumor Cells, Cultured | 1995 |
[Specific curative effects of nitrosourea drugs on tumor cells with Mer--phenotype in Chinese].
Topics: Animals; Carmustine; Female; Humans; Liver Neoplasms; Methyltransferases; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Nimustine; O(6)-Methylguanine-DNA Methyltransferase; Phenotype; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 1993 |
[Intravascular surgery for brain tumors].
Topics: Brain Neoplasms; Carmustine; Chemoembolization, Therapeutic; Humans; Meningeal Neoplasms; Meningioma; Nimustine | 1993 |
Cytotoxicity of fluoroethylating agents is potentiated by O6-benzylguanine.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Carmustine; Cell Survival; Drug Synergism; Guanine; HeLa Cells; Humans; Iodoacetamide; Lomustine; Nimustine | 1996 |
Multidrug resistance in glioblastoma. Chemosensitivity testing and immunohistochemical demonstration of P-glycoprotein.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain Neoplasms; Carmustine; Cell Survival; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Glioblastoma; Immunohistochemistry; Methotrexate; Mitoxantrone; Nimustine; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1998 |
[Expression and functions of adaptive response genes in Escherichia coli treated with mono- and bifunctional alkylating agents. Interference with SOS response].
Topics: Adaptation, Physiological; Antineoplastic Agents, Alkylating; Biological Evolution; Carmustine; Escherichia coli; Gene Expression Regulation, Bacterial; Nimustine; Operon; SOS Response, Genetics | 1999 |
Poly(ADP-ribose) polymerase-independent potentiation of nitrosourea cytotoxicity by 3-aminobenzamide in human malignant glioma cells.
Topics: Benzamides; Binding Sites; Carmustine; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; G2 Phase; Glioma; Humans; Lomustine; Methylnitrosourea; Mitosis; Nimustine; Nitrosourea Compounds; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Tumor Cells, Cultured | 2000 |
Protection of hematopoietic cells from O(6)-alkylation damage by O(6)-methylguanine DNA methyltransferase gene transfer: studies with different O(6)-alkylating agents and retroviral backbones.
Topics: Alkylating Agents; Alkylation; Animals; Carmustine; Cells, Cultured; Colony-Forming Units Assay; Dacarbazine; DNA Damage; DNA, Complementary; Drug Resistance; Genetic Vectors; Hematopoietic Stem Cells; Humans; Lomustine; Mice; Moloney murine leukemia virus; Nimustine; O(6)-Methylguanine-DNA Methyltransferase; Recombinant Fusion Proteins; Retroviridae; Sarcoma Viruses, Murine; Spleen Focus-Forming Viruses; Temozolomide; Terminal Repeat Sequences; Transfection | 2001 |
Resistance of human malignant intracranial tumors in vitro: potential guidelines to clinical therapy?
Topics: Antineoplastic Agents; Brain Neoplasms; Carmustine; Cell Division; Drug Resistance, Neoplasm; Humans; Models, Biological; Nimustine; Tumor Cells, Cultured | 1989 |
Nitrosourea efficacy in high-grade glioma: a survival gain analysis summarizing 504 cohorts with 24193 patients.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carmustine; Clinical Trials as Topic; Cohort Studies; Data Interpretation, Statistical; Databases, Factual; Female; Glioblastoma; Glioma; Humans; Lomustine; Male; Nimustine; Nitrosourea Compounds; Reproducibility of Results; Selection Bias; Survival Analysis; Treatment Outcome | 2008 |
Carmustine-resistant cancer cells are sensitized to temozolomide as a result of enhanced mismatch repair during the development of carmustine resistance.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cadmium Chloride; Carmustine; Cell Line, Tumor; Cell Proliferation; Comet Assay; Dacarbazine; DNA Mismatch Repair; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Guanine; Humans; Hydroxylamines; Nimustine; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Temozolomide | 2008 |
Nimustine hydrochloride: the first crystal structure determination of a 2-chloroethyl-N-nitrosourea hydrochloride derivative by X-ray powder diffraction and solid-state NMR.
Topics: Carmustine; Crystallography, X-Ray; Hydrogen Bonding; Magnetic Resonance Spectroscopy; Models, Molecular; Nimustine; Powders; X-Ray Diffraction | 2012 |
F2A sequence linking MGMT(P140K) and MDR1 in a bicistronic lentiviral vector enables efficient chemoprotection of haematopoietic stem cells.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carmustine; Cell Survival; Cloning, Molecular; Cytoprotection; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Doxorubicin; Genetic Vectors; Hematopoietic Stem Cells; HL-60 Cells; Humans; K562 Cells; Lentivirus; Nimustine; Paclitaxel; Peptides; Real-Time Polymerase Chain Reaction; Temozolomide; Transgenes; Tumor Suppressor Proteins | 2012 |
Concentration rather than dose defines the local brain toxicity of agents that are effectively distributed by convection-enhanced delivery.
Topics: Animals; Antineoplastic Agents; Brain; Carmustine; Convection; Corpus Striatum; Diffusion; Dose-Response Relationship, Drug; Doxorubicin; Drug Delivery Systems; Immunohistochemistry; Male; Nimustine; Polyethylene Glycols; Rats, Inbred F344 | 2014 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |